Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Hematology Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Hematology Market, United States 10
3.1 Hematology Market, United States, Revenue ($m), 2010-2017 10
3.2 Hematology Market, United States, Revenue ($m), 2017-2024 12
3.3 Hematology Market, United States, Volume (Units), 2010-2017 38
3.4 Hematology Market, United States, Volume (Units), 2017-2024 40
3.5 Hematology Market, United States, Average Price ($), 2010-2024 58
3.6 Hematology Market, United States, Distribution Share by Revenue ($m), 2017 62
3.7 Hematology Market, United States, Company Share by Revenue ($m), 2017 63
4 Overview of Key Companies in United States, Hematology Market 65
4.1 Sysmex Corp 65
4.2 F. Hoffmann-La Roche Ltd 65
4.3 Beckman Coulter Inc 65
4.4 Abbott Laboratories 65
4.5 Siemens Healthcare GmbH 66
4.6 Instrumentation Laboratory Company 66
4.7 Thermo Fisher Scientific Inc 66
4.8 Sigma-Aldrich Corp 66
4.9 Sekisui Diagnostics LLC 67
4.10 Bio-Rad Laboratories Inc 67
4.11 Becton Dickinson and Co 67
5 Hematology Market Pipeline Products 68
6 Financial Deals Landscape 69
6.1 Asset Transactions 69
6.2 Debt Offerings 70
6.3 Equity Offerings 88
6.4 Merger 95
6.5 Partnerships 98
6.6 Private Equity 102
6.7 Venture Financing 104
7 Recent Developments 110
7.1 Corporate Communications 110
7.2 Financial Announcements 126
7.3 Government and Public Interest 189
7.4 Legal And Regulatory 190
7.5 Other Significant Developments 193
7.6 Product News 199
7.7 Research And Development 202
7.8 Strategy And Business Planning 203
8 Appendix 206
8.1 Research Methodology 207
8.2 GlobalData Consulting 211
8.3 Contact Us 212
8.4 Disclaimer 212
List of Tables
Table 1: Hematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 16
Table 2: Hematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 18
Table 3: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 20
Table 4: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 22
Table 5: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 24
Table 6: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 7: Hemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 28
Table 8: Immunohematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 30
Table 9: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 32
Table 10: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 34
Table 11: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 36
Table 12: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 38
Table 13: Hemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 40
Table 14: Immunohematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 42
Table 15: Hematology Market, United States, Volume (Units), Historic, 2010-2017 44
Table 16: Hematology Market, United States, Volume (Units), Forecast, 2017-2024 46
Table 17: Hematology Analyzers Market, United States, Volume (Units), Historic, 2010-2017 48
Table 18: Hematology Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 50
Table 19: Hematology Reagents Market, United States, Volume (Units), Historic, 2010-2017 52
Table 20: Hemostasis Market, United States, Volume (Units), Historic, 2010-2017 54
Table 21: Hematology Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 56
Table 22: Hematology Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 58
Table 23: Hematology Reagents Market, United States, Volume (Units), Forecast, 2017-2024 60
Table 24: Hemostasis Market, United States, Volume (Units), Forecast, 2017-2024 62
Table 25: Hematology Market, United States, Average Price ($) Historic, 2010-2017 63
Table 26: Hematology Market, United States, Average Price ($), Forecast, 2017-2024 65
Table 27: Hematology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 67
Table 28: Hematology Market, United States, Company Share by Revenue ($m), USD Constant, 2017 69
Table 29: Hematology Market Pipeline Products 73
Table 30: Polymedco Acquires US Distribution Rights to PATHFAST Product Line from LSI Medience 74
Table 31: Rosetta Genomics Raises USD2 Million in Private Placement of Debentures and Warrants 75
Table 32: Rennova Health to Raise USD2.1 Million in Private Placement of Debentures and Warrants 76
Table 33: LabCorp Raises USD600 Million in Public Offering of 3.25% Notes Due 2024 77
Table 34: LabCorp Raises USD600 Million in Public Offering of 3.6% Notes Due 2027 79
Table 35: Becton, Dickinson to Raise USD725 Million in Public Offering of 2.133% Notes Due 2019 81
Table 36: Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020 82
Table 37: Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022 83
Table 38: Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022 84
Table 39: Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024 85
Table 40: Becton, Dickinson to Raise USD2.4 Billion in Public Offering of 3.7% Notes Due 2027 86
Table 41: Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047 87
Table 42: Becton, Dickinson to Raise USD788 Million in Public Offering of 0.368% Notes Due 2019 88
Table 43: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million 89
Table 44: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million 91
Table 45: Vermillion Plans to Raise up to USD50 Million in Public Offering of Securities 93
Table 46: Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares 94
Table 47: Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares 96
Table 48: Vermillion Plans to Raise up to USD6.8 in Public Offering of Shares 98
Table 49: Vermillion Raises USD5.2 Million in Private Placement of Shares and Warrants 99
Table 50: Aviragen Therapeutics to Merge with Vaxart 100
Table 51: Grail to Merge with Cirina 102
Table 52: Genoptix and Bionano Genomics Enter into Co-Development Agreement 103
Table 53: Grifols and Beckman Coulter Enter into Distribution Agreement 104
Table 54: Aferetica Enters into Partnership with CytoSorbents 105
Table 55: Sophia Genetics Enters into Agreement with ArcherDx 106
Table 56: Avista Capital Partners to Acquire Miraca Life Sciences from Miraca Holdings 107
Table 57: SenGenix Raises USD6.3 Million in Financing 109
Table 58: VentureMed Group Raises USD15 Million in Series B Financing 110
Table 59: Magnolia Medical Tech Raises Additional USD7.3 Million in Series B Financing 111
Table 60: Bioptix Raises USD2.3 Million in Venture Financing 112
Table 61: Exactus Raises Funds through Venture Financing 113
Table 62: Protege Biomedical Raises USD0.3 Million in Venture Financing 114
Table 63: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 214
List of Figures
Figure 1: Hematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 15
Figure 2: Hematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 17
Figure 3: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 19
Figure 4: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 21
Figure 5: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 23
Figure 6: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 25
Figure 7: Hemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 27
Figure 8: Immunohematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 29
Figure 9: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 31
Figure 10: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 33
Figure 11: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 35
Figure 12: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 37
Figure 13: Hemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 39
Figure 14: Immunohematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 41
Figure 15: Hematology Market, United States, Volume (Units), Historic, 2010-2017 43
Figure 16: Hematology Market, United States, Volume (Units), Forecast, 2017-2024 45
Figure 17: Hematology Analyzers Market, United States, Volume (Units), Historic, 2010-2017 47
Figure 18: Hematology Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 49
Figure 19: Hematology Reagents Market, United States, Volume (Units), Historic, 2010-2017 51
Figure 20: Hemostasis Market, United States, Volume (Units), Historic, 2010-2017 53
Figure 21: Hematology Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 55
Figure 22: Hematology Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 57
Figure 23: Hematology Reagents Market, United States, Volume (Units), Forecast, 2017-2024 59
Figure 24: Hemostasis Market, United States, Volume (Units), Forecast, 2017-2024 61
Figure 25: Hematology Market, United States, Company Share (%) 2017 68
